"This is one of the main conclusions to be explained by the President of the Spanish Association of Orphan and Ultra-Orphan Drugs (AELMHU), Luis Cruz, during his presentation at the round table on Advances in Translational Research, at the VII International Congress on Orphan Drugs and Rare Diseases, which is being held in Seville from 12 to 14 February.

According to Cruz, "there are currently 7,500 little-known diseases, and there is only a minimum of scientific knowledge about 10% of them, which is why the efforts made by pharmaceutical laboratories dedicated to the development of orphan drugs should be highlighted".